We have located links that may give you full text access.
Meta-Analyses in Plastic Surgery: Can We Trust Their Results?
Plastic and Reconstructive Surgery 2019 May 11
BACKGROUND: Meta-analyses are common in the plastic surgery literature, but studies concerning their quality are lacking. The authors assessed the overall quality of meta-analyses in plastic surgery, and attempted to identify variables associated with scientific quality.
METHODS: A systematic review of meta-analyses published in seven plastic surgery journals between 2007 and 2017 was undertaken using a computerized search. Publication descriptors and methodological and statistical details were extracted. Articles were assessed using the AMSTAR (A Measurement Tool to Assess Systematic Reviews) and AMSTAR 2 instruments.
RESULTS: Seventy-four studies were included. The number of meta-analyses per year increased. Most meta-analyses assessed a single intervention (59.5 percent), and pooled a mean of 20.9 studies (range: 2-134), including a mean of 2,463 patients (range: 44-14,884). Most meta-analyses were published in Plastic & Reconstructive Surgery (44.6 percent), and included mid-level evidence (II to IV) primary studies. Only 16.2 percent of meta-analyses included randomized controlled trials. Meta-analyses generally reported positive (81.1 percent) and significant results (77.0 percent). Median AMSTAR score was 7/11 (interquartile range=5-8). AMSTAR scores correlated with year of publication (p=0.04, R=0.24). Higher AMSTAR scores correlated with more recent meta-analyses that provided a rationale for statistical pooling, and appropriately managed methodological heterogeneity (r=0.66, p<0.01).
CONCLUSIONS: Despite an increase in the number and quality of meta-analyses, these studies are at high risk of bias due to the low level of evidence of included primary studies and heterogeneity within and between primary studies. Plastic surgeons should be aware of the pitfalls of conducting and interpreting meta-analyses.
METHODS: A systematic review of meta-analyses published in seven plastic surgery journals between 2007 and 2017 was undertaken using a computerized search. Publication descriptors and methodological and statistical details were extracted. Articles were assessed using the AMSTAR (A Measurement Tool to Assess Systematic Reviews) and AMSTAR 2 instruments.
RESULTS: Seventy-four studies were included. The number of meta-analyses per year increased. Most meta-analyses assessed a single intervention (59.5 percent), and pooled a mean of 20.9 studies (range: 2-134), including a mean of 2,463 patients (range: 44-14,884). Most meta-analyses were published in Plastic & Reconstructive Surgery (44.6 percent), and included mid-level evidence (II to IV) primary studies. Only 16.2 percent of meta-analyses included randomized controlled trials. Meta-analyses generally reported positive (81.1 percent) and significant results (77.0 percent). Median AMSTAR score was 7/11 (interquartile range=5-8). AMSTAR scores correlated with year of publication (p=0.04, R=0.24). Higher AMSTAR scores correlated with more recent meta-analyses that provided a rationale for statistical pooling, and appropriately managed methodological heterogeneity (r=0.66, p<0.01).
CONCLUSIONS: Despite an increase in the number and quality of meta-analyses, these studies are at high risk of bias due to the low level of evidence of included primary studies and heterogeneity within and between primary studies. Plastic surgeons should be aware of the pitfalls of conducting and interpreting meta-analyses.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app